Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome
Open Access
- 1 May 2005
- Vol. 54 (5) , 601-607
- https://doi.org/10.1136/gut.2004.047423
Abstract
Background and aims: Irritable bowel syndrome (IBS) is a disorder of intestinal hypersensitivity and altered motility, exacerbated by stress. Functional magnetic resonance imaging (fMRI) during painful rectal distension in IBS has demonstrated greater activation of the anterior cingulate cortex (ACC), an area relevant to pain and emotions. Tricyclic antidepressants are effective for IBS. The aim of this study was to determine if low dose amitriptyline reduces ACC activation during painful rectal distension in IBS to confer clinical benefits. Secondary aims were to identify other brain regions altered by amitriptyline, and to determine if reductions in cerebral activation are greater during mental stress. Methods: Nineteen women with painful IBS were randomised to amitriptyline 50 mg or placebo for one month and then crossed over to the alternate treatment after washout. Cerebral activation during rectal distension was compared between placebo and amitriptyline groups by fMRI. Distensions were performed alternately during auditory stress and relaxing music. Results: Rectal pain induced significant activation of the perigenual ACC, right insula, and right prefrontal cortex. Amitriptyline was associated with reduced pain related cerebral activations in the perigenual ACC and the left posterior parietal cortex, but only during stress. Conclusions: The tricyclic antidepressant amitriptyline reduces brain activation during pain in the perigenual (limbic) anterior cingulated cortex and parietal association cortex. These reductions are only seen during stress. Amitriptyline is likely to work in the central nervous system rather than peripherally to blunt pain and other symptoms exacerbated by stress in IBS.Keywords
This publication has 48 references indexed in Scilit:
- Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).Gastroenterology, 2003
- Imipramine decreases oesophageal pain perception in human male volunteersGut, 1998
- Identification of human brain loci processing esophageal sensation using positron emission tomographyGastroenterology, 1997
- Subgenual prefrontal cortex abnormalities in mood disordersNature, 1997
- Regional cerebral activity in normal and pathological perception of visceral painGastroenterology, 1997
- Pain Processing in Four Regions of Human Cingulate Cortex Localized with Co‐registered PET and MR ImagingEuropean Journal of Neuroscience, 1996
- Altered rectal perception is a biological marker of patients with irritable bowel syndromeGastroenterology, 1995
- Effects of desipramine on irritable bowel syndrome compared with atropine and placeboDigestive Diseases and Sciences, 1987
- Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndromeGut, 1973
- Pain “Relief” by Frontal CingulumotomyJournal of Neurosurgery, 1962